Oncomatryx Biopharma

Derio, Spain · Founded 2009 · Privately Held (backing)

Developer of stroma-targeted precision drugs and diagnostics intended to fight against invasive tumours. Oncomatryx Biopharma is based in Derio, Spain and was founded in 2009. Its last reported valuation was $112 million in Mar 2022. It has raised $146 million.

Last reported valuation
$111.8M
Oct 2026
Priced at
—
Total raised
$146.0M
Last round
—

Who backs Oncomatryx Biopharma?

9 investors
InvestorType
European Innovation CouncilVenture capital
INNVIERTE SICCOther
Basque GovernmentOther
Bilbao Bizkaia Kutxa—
Diputación Foral de Bizkaia—
Ekarpen—
Ekarpen Private Equity—
European Innovation Council (Belgium)—
Kutxa Fundazioa—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Oncomatryx Biopharma investors

9 investors are on record for Oncomatryx Biopharma, including European Innovation Council, INNVIERTE SICC, Basque Government and Bilbao Bizkaia Kutxa.

Free account
More of Oncomatryx Biopharma with a free account
  • ·Watch Oncomatryx Biopharma: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 9 firms already write checks for companies like Oncomatryx Biopharma. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View